First Time Loading...

Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 3.35 USD 1.52% Market Closed
Updated: May 3, 2024

Repare Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repare Therapeutics Inc
Revenue Peer Comparison

Comparables:
ZYME
TH
FUSN
AUPH
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Revenue
$78.1m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
27%
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

Repare Therapeutics Inc
Revenue Breakdown

Breakdown by Geography
Repare Therapeutics Inc

Total Revenue: 51.1m USD
100%
United States: 26.1m USD
51%
Switzerland: 14.5m USD
28.4%
Japan: 10.5m USD
20.5%

Breakdown by Segments
Repare Therapeutics Inc

Not Available

See Also

What is Repare Therapeutics Inc's Revenue?
Revenue
51.1m USD

Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Revenue amounts to 51.1m USD.

What is Repare Therapeutics Inc's Revenue growth rate?
Revenue CAGR 3Y
700%

Over the last year, the Revenue growth was -61%. The average annual Revenue growth rates for Repare Therapeutics Inc have been 700% over the past three years .